EZZ Life Science Holdings Ltd
Research EZZ Life Science Holdings Ltd (EZZ) on Bullrun: market cap AUD 22.36M, P/E 7.7, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEZZ
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 22.36M
- P/E7.7
- Dividend yield3.1%
- Financial periodFY2025
- RevenueAUD 66.87M
- Revenue growth0.6%
- Net incomeAUD 6.73M
- Free cash flowAUD 4.09M
- Gross margin74.3%
Valuation Snapshot
latest market cap is AUD 22.36M; P/E is 7.7; dividend yield is 3.1%.
Peer valuation comparison
Latest P/E is 7.74x versus a Healthcare sector median of 24.46x (68.4% below).
Latest dividend yield is 3.13% versus a Healthcare sector median of 2.11% (48.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 66.87M | AUD 6.73M | AUD 4.09M | 74.3% | 0.15 | AUD 20.85M | AUD 304.49K | AUD 28.09M |
| FY2024 | AUD 66.44M | AUD 6.96M | AUD 5.73M | 76.7% | 0.16 | AUD 19.02M | AUD 123.86K | AUD 21.32M |
| FY2023 | AUD 37.14M | AUD 3.63M | AUD 3.91M | 76.8% | 0.09 | AUD 13.83M | AUD 478.59K | AUD 14.58M |
| FY2022 | AUD 15.02M | AUD 1.31M | AUD 1.89M | 50.0% | 0.03 | AUD 10.46M | AUD 104.57K | AUD 11.39M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 22.36M | 7.7 | 8.4% | 0.04 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.04 AUD, yield 3.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.04 AUD |
| FY2024 | 0.04 AUD |
| FY2023 | 0.02 AUD |
| FY2022 | 0 AUD |
About EZZ Life Science Holdings Ltd
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is EZZ Life Science Holdings Ltd's market cap?
EZZ Life Science Holdings Ltd's market capitalization is AUD 22.36M.
What is EZZ Life Science Holdings Ltd's P/E ratio?
EZZ Life Science Holdings Ltd's price-to-earnings (P/E) ratio is 7.7.
Does EZZ Life Science Holdings Ltd pay a dividend?
EZZ Life Science Holdings Ltd has a dividend yield of 3.1%.
What does EZZ Life Science Holdings Ltd do?
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online.